Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies
Description
CONCLUSIONS: In conclusion, the probability of emerging mutations arising in response to mAbs is significant, emphasizing the crucial need to investigate these mutations thoroughly and assess their impact on patients and the evolutionary trajectory
